Researchers Announce Breakthrough in Their Study of Hospital Superbug
Researchers at Queen’s University Belfast have developed a cutting-edge new medical therapy that could protect UK hospital patients against a lethal superbug. The new treatment, which uses a molecule called an inhibitor to prevent the hospital superbug Klebsiella pneumonia from blocking the body’s natural defenses, has the potential to save thousands of lives in the UK each year. Klebsiella, which has mortality rates of 25 percent to 60 percent, can cause bladder infections and pneumonia and is resistant to all major antibiotics.
Professor Jose Bengoechea, from the School of Medicine, Dentistry and Biomedical Sciences at Queen’s University Belfast.
Researchers at Queen’s University Belfast have developed a cutting-edge new medical therapy that could protect UK hospital patients against a lethal superbug. The new treatment, which uses a molecule called an inhibitor to prevent the hospital superbug Klebsiella pneumonia from blocking the body’s natural defenses, has the potential to save thousands of lives in the UK each year. Klebsiella, which has mortality rates of 25 percent to 60 percent, can cause bladder infections and pneumonia and is resistant to all major antibiotics.
The research team, from the School of Medicine, Dentistry and Biomedical Sciences at Queen’s, found that Klebsiella can survive inside white blood cells called macrophages, which are meant to protect the human body from infection. The superbug takes over a protein in the blood cell called Akt, paralyzing the cell and making it the perfect shelter to avoid being killed by antibiotics.
The team showed that by treating the cell with the inhibitor -- which stops Akt protein from working - the blood cell is once again capable of killing Klebsiella and the infection can be completely eliminated.
Team leader Jose Bengoechea, from the School of Medicine, Dentistry and Biomedical Sciences at Queen’s, says, “The global problem of antimicrobial resistance is fast becoming one of the major health issues of modern times. Of particular concern is the mounting prevalence of infections caused by Klebsiella pneumonia which has been identified as an urgent threat to human health by the UK government and the World Health Organization due to extremely drug resistant strains. Our research has helped us gain a better understanding of the vulnerable pathways of human defenses, meaning we have been able to develop a potentially ground-breaking new therapy that will block the bug and stop it in its tracks. This is the latest example of the commitment of researchers and staff at Queen’s to advancing knowledge and achieving excellence for the benefit of society.”
The research team at Queen’s plan to carry out pre-clinical trials over the next months to further confirm their findings and move the therapy forward into human clinical trials.
Read the research report at: http://onlinelibrary.wiley.com/doi/10.1111/cmi.12466/abstract
Source: Queen's University Belfast
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.
